Fundz

Lantheus Announces Acquisition Of Cerveau Technologies, Inc., Expanding Imaging Pipeline Into Alzheimer’S Disease

PUBLIC · LNTHFeb 06, 2023

Acquiring Company

Lantheus Holdings

Acquired Company

Cerveau

BedfordBiotechnologyHealth CareTherapeuticsInformation TechnologyHealth Care

Description

Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced it has acquired Knoxville-based Cerveau Technologies, Inc. (“Cerveau”). Cerveau’s asset is MK-6240, a second-generation F 18-labeled positron emission tomography (“PET”) imaging agent that targets Tau tangles in Alzheimer’s disease.

Quick answer

Lantheus Holdings is acquiring Cerveau, announced February 6, 2023. Lantheus Holdings is based in Bedford, Massachusetts, United States.

How much did Lantheus Holdings pay for Cerveau?
The deal value was not disclosed.
What does Lantheus Holdings do?
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.
Where are Lantheus Holdings and Cerveau based?
Lantheus Holdings is based in Bedford, Massachusetts, United States.
Who are the decision-makers at Lantheus Holdings?
Fundz holds 1 contact at Lantheus Holdings. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Therapeutics and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Lantheus Holdings, and when

When Lantheus Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Lantheus Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lantheus Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lantheus Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lantheus Holdings

Location

201 Burlington Road, South Building

Bedford, Massachusetts, United States

About

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lantheus Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Amanda
Likely contact at this company
••••••••@••••••••

See Amanda's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lantheus Holdings's next move

Learn about Strategic plan

Frequently asked

Who acquired Cerveau?

Cerveau was acquired by Lantheus Holdings, based in Bedford. The deal was reported on February 6, 2023. Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus Holdings is publicly traded (LNTH) and operates in Biotechnology.

When did Lantheus Holdings acquire Cerveau?

Lantheus Holdings's acquisition of Cerveau was reported on February 6, 2023. Lantheus Holdings, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Cerveau do?

Cerveau’s vision is to be the premier provider of information and technology to researchers and clinicians in order to improve brain health. For more information, visit www.cerveautechnologies.com. It is privately held, operating in Information Technology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.